M G Zurlo - JoVE Visualize

Showing results (11-20 of 19) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 19 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I studyD C Johannessen, T Engan, E Di Salle, et al.

Pediatric Hematology and Oncology|January 1, 1986

Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemiaM R Rossi, G Masera, M G Zurlo, et al.

European Journal of Cancer (Oxford, England : 1990)|February 21, 1998

Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study GroupB Thürlimann, R Paridaens, D Serin, et al.

Cancer|December 15, 1988

Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative studyA Ceci, M de Terlizzi, R Colella, et al.

European Journal of Cancer & Clinical Oncology|May 1, 1987

Late deaths and second primary malignancies among long-term survivors of childhood cancer: an Italian multicentre studyB Terracini, G Pastore, M G Zurlo, et al.

Lancet (London, England)|July 1, 1989

Survival and causes of death in thalassaemia majorM G Zurlo, P De Stefano, C Borgna-Pignatti, et al.

Medical and Pediatric Oncology|January 1, 1987

Health status of young children with cancer following discontinuation of therapyG Pastore, M G Zurlo, A Acquaviva, et al.

Anti-Cancer Drugs|November 21, 1998

Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I studyR Paridaens, J Thomas, J Wildiers, et al.

Anti-Cancer Drugs|May 4, 2001

Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxelJ M Meerum Terwogt, W W ten Bokkel Huinink, J H Schellens, et al.

Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 19 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I studyD C Johannessen, T Engan, E Di Salle, et al.

Pediatric Hematology and Oncology|January 1, 1986

Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemiaM R Rossi, G Masera, M G Zurlo, et al.

European Journal of Cancer (Oxford, England : 1990)|February 21, 1998

Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study GroupB Thürlimann, R Paridaens, D Serin, et al.

Cancer|December 15, 1988

Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative studyA Ceci, M de Terlizzi, R Colella, et al.

European Journal of Cancer & Clinical Oncology|May 1, 1987

Late deaths and second primary malignancies among long-term survivors of childhood cancer: an Italian multicentre studyB Terracini, G Pastore, M G Zurlo, et al.

Lancet (London, England)|July 1, 1989

Survival and causes of death in thalassaemia majorM G Zurlo, P De Stefano, C Borgna-Pignatti, et al.

Medical and Pediatric Oncology|January 1, 1987

Health status of young children with cancer following discontinuation of therapyG Pastore, M G Zurlo, A Acquaviva, et al.

Anti-Cancer Drugs|November 21, 1998

Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I studyR Paridaens, J Thomas, J Wildiers, et al.

Anti-Cancer Drugs|May 4, 2001

Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxelJ M Meerum Terwogt, W W ten Bokkel Huinink, J H Schellens, et al.

Pageof 2